| Data | Descrição | Vacina | Quantidade 1° dose | Quantidade 2° dose | Quantidade 1° dose extra | Quantidade 2° dose extra | Quantidade de doses indigena | Total |
| 21/07/2021 | D1 POP GERAL | Butantan/CoronaVac | 40 | 0 | 0 | 0 | 0 | 40 |
| 21/07/2021 | D2 COMORBIDADES/IDOSOS - D1 POP GERAL | Fiocruz/Oxford/AstraZeneca | 105 | 155 | 0 | 0 | 0 | 260 |
| 29/07/2021 | D1 Doc. 10669649 | Butantan/CoronaVac | 2 | 6 | 0 | 0 | 0 | 8 |
| 29/07/2021 | D1 DOC. 10669649 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 78 | 0 | 0 | 0 | 0 | 78 |
| 29/07/2021 | D1 DOC. 10669649 | Butantan/CoronaVac | 140 | 0 | 0 | 0 | 0 | 140 |
| 29/07/2021 | Doc. 10669649 | Fiocruz/Oxford/AstraZeneca | 0 | 150 | 0 | 0 | 0 | 150 |
| 03/08/2021 | Doc. 10717545 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 240 | 0 | 0 | 0 | 0 | 240 |
| 05/08/2021 | Doc. 10761230 | Butantan/CoronaVac | 60 | 0 | 0 | 0 | 0 | 60 |
| 05/08/2021 | Doc. 10738829 | Butantan/CoronaVac | 140 | 40 | 0 | 0 | 0 | 180 |
| 05/08/2021 | Doc. 10738829 | Fiocruz/Oxford/AstraZeneca | 0 | 285 | 0 | 3 | 0 | 288 |
| 05/08/2021 | DOC. 10761230 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 204 | 0 | 0 | 0 | 0 | 204 |
| 09/08/2021 | Doc. 10774375 | Janssen Covid-19 Vaccine | 15 | 0 | 0 | 0 | 0 | 15 |
| 09/08/2021 | Doc. 10774375 | Fiocruz/Oxford/AstraZeneca | 190 | 5 | 1 | 0 | 0 | 196 |
| 09/08/2021 | DOC. 10774375 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 306 | 0 | 0 | 0 | 0 | 306 |
| 09/08/2021 | DOC. 10774375 | Butantan/CoronaVac | 40 | 0 | 0 | 0 | 0 | 40 |
| 12/08/2021 | Doc. 10826637 | Butantan/CoronaVac | 50 | 150 | 0 | 0 | 0 | 200 |
| 12/08/2021 | Doc. 10826637 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 258 | 0 | 0 | 0 | 0 | 258 |
| 16/08/2021 | Doc. 10860811 | Butantan/CoronaVac | 80 | 0 | 0 | 0 | 0 | 80 |
| 16/08/2021 | Doc. 10860811 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 150 | 0 | 0 | 0 | 0 | 150 |
| 16/08/2021 | Doc. 10852541 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 72 | 0 | 0 | 0 | 0 | 78 |
| 18/08/2021 | Doc. 10903793 | Butantan/CoronaVac | 60 | 200 | 0 | 0 | 0 | 260 |
| 18/08/2021 | Doc. 70903793 | Fiocruz/Oxford/AstraZeneca | 0 | 240 | 0 | 0 | 0 | 240 |
| 20/08/2021 | DOC. 10925855 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 372 | 12 | 0 | 0 | 0 | 384 |
| 21/08/2021 | Doc. 10938396 | Butantan/CoronaVac | 130 | 40 | 0 | 0 | 0 | 170 |
| 25/08/2021 | DOC. 10980300 | Fiocruz/Oxford/AstraZeneca | 0 | 680 | 0 | 0 | 0 | 680 |
| 25/08/2021 | DOC. 10980300 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 30 | 0 | 0 | 0 | 30 |
| 25/08/2021 | DOC. 10980300 | Butantan/CoronaVac | 40 | 50 | 0 | 0 | 0 | 90 |
| 25/08/2021 | DOC. 10974559 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 216 | 0 | 2 | 0 | 0 | 218 |
| 28/08/2021 | DOC. 11003892 D1 12 A 17 ANOS | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 138 | 0 | 0 | 0 | 0 | 138 |
| 28/08/2021 | DOC. 11021713 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 36 | 438 | 0 | 0 | 0 | 474 |
